LifeVantage to Participate in Water Tower Fireside Chat on Thursday, December 11, 2025 GlobeNewswire December 10, 2025 SALT LAKE CITY, Dec. 10, 2025 (GLOBE NEWSWIRE) — LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and […]

Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research GlobeNewswire December 10, 2025 Partnership aims to destigmatize androgenetic alopecia and highlight the need for new therapeutic options that address the root cause of disease Donovan to share his personal journey at Absci's upcoming Key Opinion Leader seminar

LexisNexis Unveils Next-Generation Protege General AI, the Most Integrated Legal AI Workflow Solution Protege(TM) General AI seamlessly unifies LexisNexis authoritative content, customer legal documents, and open web insights for expanded AI-driven work in a single secure legal AI workflow solution GlobeNewswire December 10, 2025 NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) — LexisNexis(R) Legal &

Harvey Milk Terminal 1 at San Francisco International Airport Wins Prix Versailles World Title The international jury honors the terminal for its cultural significance, human-centered design, and climate-forward performance GlobeNewswire December 10, 2025 SAN FRANCISCO, Dec. 10, 2025 (GLOBE NEWSWIRE) — Gensler, the world's leading architecture, design and planning firm, is pleased to announce that

PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them GlobeNewswire December 10, 2025 DELRAY BEACH, Fla., Dec. 10, 2025 (GLOBE NEWSWIRE) — PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the “Company”), today unveiled its new Holiday Collection, a curated selection of health, wellness, and lifestyle

ScanTech AI Systems Strengthens Strategic Leadership to Accelerate Growth and Global Commercial Execution with Appointment of Michael D.P. Cavanaugh to Board of Directors GlobeNewswire December 10, 2025 Michael D.P. Cavanaugh Atlanta, GA, Dec. 10, 2025 (GLOBE NEWSWIRE) — ScanTech AI Systems Inc. (Nasdaq: STAI) (“ScanTech AI” or the “Company”), a developer of advanced AI-powered security

Servus Credit Union rewards members with $83 million through annual Profit Share(R) program GlobeNewswire December 10, 2025 EDMONTON, Alberta, Dec. 10, 2025 (GLOBE NEWSWIRE) — In a move unlike other financial institutions, Servus Credit Union Ltd. (Servus) announced today it is sharing $83 million in profits with its members across Alberta. Through its annual Profit

NuCana Presents Latest Data Demonstrating Clinical Activity and Favorable Safety for NUC-7738 in Patients with PD-1-Resistant Melanoma Data Presented at ESMO IO 2025 include Partial Responses, Durable Disease Control, and No New Safety Signals, Reinforcing Earlier Findings GlobeNewswire December 10, 2025 EDINBURGH, United Kingdom, Dec. 10, 2025 (GLOBE NEWSWIRE) — NuCana plc (NASDAQ: NCNA) (“NuCana”

Questex's Fierce Network Announces Winners of the 2025 Fierce Network Innovation Awards GlobeNewswire December 10, 2025 NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) — Questex's Fierce Network, a mega portal to meet the needs of decision makers throughout the global communications industry, today announces the winners of the 2025 Fierce Network Innovation Awards. The program

Ajax Therapeutics Receives Orphan Drug Designation from the U.S. FDA for AJ1-11095 for the Treatment of Myelofibrosis AJ1-11095 is a first-in-class Type II JAK2 inhibitor currently in a Phase 1 study for the treatment of patients with myelofibrosis, previously treated with a Type I JAK2 inhibitor GlobeNewswire December 10, 2025 NEW YORK and CAMBRIDGE, Mass.,